 BOSTON--BUSINESS WIRE--Gamida Cell Ltd. Nasdaq: GMDA, the leader in the development of NAM-enabled cell therapy candidates for patients with hematologic and solid cancers and other serious diseases, announces that company management will present its corporate highlights at the Jefferies Healthcare Conference, June 8, 2022 with a presentation at 11:00 a.m. ET in New York, NY. Management will discuss 2022 catalysts and potential milestones including the U.S. market opportunity for omidubicel 